<DOC>
	<DOCNO>NCT01615679</DOCNO>
	<brief_summary>Non-interventional study gain information therapy progression routine treatment adult attention-deficit/hyperactivity disorder ( ADHD ) . Main focus improvement clinical global impression ( CGI ) comparison outcome randomize , control study .</brief_summary>
	<brief_title>Integrated Diagnosis Treatment Adults With Attention-deficit/Hyperactivity Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<criteria>Adult patient newly diagnose ADHD Known sensitivity methylphenidate excipients Glaucoma Phaeochromocytoma During treatment nonselective , irreversible monoamine oxidase ( MAO ) inhibitor , within minimum 14 day discontinue drug , due risk hypertensive crisis Hyperthyroidism Thyrotoxicosis Diagnosis history severe depression , anorexia nervosa/anorexic disorder , suicidal tendency , psychotic symptom , severe mood disorder , mania , schizophrenia , psychopathic/borderline personality disorder . Diagnosis history severe episodic ( Type I ) Bipolar ( affective ) Disorder ( wellcontrolled ) preexist cardiovascular disorder include severe hypertension , heart failure , arterial occlusive disease , angina , haemodynamically significant congenital heart disease , cardiomyopathy , myocardial infarction , potentially lifethreatening arrhythmias channelopathies ( disorder cause dysfunction ion channel ) preexist cerebrovascular disorder cerebral aneurysm , vascular abnormality include vasculitis stroke history pronounce anacidity stomach pH value 5.5 , therapy H2receptor blocker antacid therapy ,</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Non-interventional study</keyword>
	<keyword>Attention Deficit/Hyperactivity Disorder</keyword>
	<keyword>ADHD</keyword>
</DOC>